These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Should capitation's financial incentives be part of informed consent to treatment? La Puma J Manag Care; 1996 Apr; 5(4):49-50. PubMed ID: 10157310 [No Abstract] [Full Text] [Related]
37. Unexpected findings in identifiable stored blood samples after analysis without consent: moral arguments for and against disclosure. Verweij MF; Hamel BC Genet Couns; 2002; 13(2):115-21. PubMed ID: 12150210 [TBL] [Abstract][Full Text] [Related]
38. Post treatment duties to disclose: further aspects of informed consent. Andrew LB J Med Pract Manage; 1987; 2(4):274-8. PubMed ID: 10314231 [No Abstract] [Full Text] [Related]
39. Reconfiguring informed consent (with a little help from the capability approach). Pearson YE Am J Bioeth; 2006; 6(1):22-4; discussion W27-8. PubMed ID: 16423781 [No Abstract] [Full Text] [Related]